Atherosclerotic risk factor control in patients with peripheral arterial disease

Criqui, 1985, The prevalence of peripheral arterial disease in a defined population, Circulation, 71, 510, 10.1161/01.CIR.71.3.510 Fowkes, 1991, Edinburgh Artery Study, Int J Epidemiol, 20, 384, 10.1093/ije/20.2.384 Meijer, 1998, Peripheral arterial disease in the elderly, Arterioscler Thromb Vasc Biol, 18, 185, 10.1161/01.ATV.18.2.185 McDermott, 2002, Atherosclerotic risk factor reduction in peripheral arterial disease, J Gen Intern Med, 17, 895, 10.1046/j.1525-1497.2002.20307.x Hirsch, 2001, Peripheral arterial disease detection, awareness, and treatment in primary care, JAMA, 286, 1317, 10.1001/jama.286.11.1317 Diehm, 2004, High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients, Atherosclerosis, 172, 95, 10.1016/S0021-9150(03)00204-1 Criqui, 1992, Mortality over a period of 10 years in patients with peripheral arterial disease, N Engl J Med, 326, 381, 10.1056/NEJM199202063260605 Hertzer, 1984, Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management, Ann Surg, 199, 223, 10.1097/00000658-198402000-00016 1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 Newman, 1999, Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group, Arterioscler Thromb Vasc Biol, 19, 538, 10.1161/01.ATV.19.3.538 Smith, 2001, Circulation, 104, 1577, 10.1161/hc3801.097475 2002, Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, Circulation, 106, 3143, 10.1161/circ.106.25.3143 Chobanian, 2003, Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Hypertension, 42, 1206, 10.1161/01.HYP.0000107251.49515.c2 Leng, 1996, Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population, Int J Epidemiol, 25, 1172, 10.1093/ije/25.6.1172 Muluk, 2001, Outcome events in patients with claudication, J Vasc Surg, 33, 251, 10.1067/mva.2001.112210 Jelnes, 1986, Fate in intermittent claudication, Br Med J (Clin Res Ed), 293, 1137, 10.1136/bmj.293.6555.1137 Howell, 1989, Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity, J Vasc Surg, 9, 691, 10.1016/S0741-5214(89)70041-0 McKenna, 1991, The ratio of ankle and arm arterial pressure as an independent predictor of mortality, Atherosclerosis, 87, 119, 10.1016/0021-9150(91)90014-T McDermott, 1997, Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease, J Gen Intern Med, 12, 209, 10.1007/s11606-006-5042-4 Kalman, 2000, How do vascular surgeons perceive atherosclerotic risk factor management?, Ann Vasc Surg, 14, 652, 10.1007/s100169910116 Gottlieb, 1998, Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction, N Engl J Med, 339, 489, 10.1056/NEJM199808203390801 Freemantle, 1999, Blockade after myocardial infarction, BMJ, 318, 1730, 10.1136/bmj.318.7200.1730 Gottlieb, 2001, Comparative effects of three beta blockers (atenolol, metoprolol, and propranolol) on survival after acute myocardial infarction, Am J Cardiol, 87, 823, 10.1016/S0002-9149(00)01520-4 Viscoli, 1993, Beta-blockers after myocardial infarction, Ann Intern Med, 118, 99, 10.7326/0003-4819-118-2-199301150-00004 Lip, 2003, Treatment of hypertension in peripheral arterial disease, Cochrane Database Syst Rev, 10.1002/14651858.CD003075 Radack, 1991, Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease, Arch Intern Med, 151, 1769, 10.1001/archinte.1991.00400090063012 Yusuf, 2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients, N Engl J Med, 342, 145, 10.1056/NEJM200001203420301 Hunt, 2001, Circulation, 104, 2996, 10.1161/hc4901.102568 O’Keefe, 2001, Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease?, J Am Coll Cardiol, 37, 1, 10.1016/S0735-1097(00)01044-5 Pekkanen, 1990, Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease, N Engl J Med, 322, 1700, 10.1056/NEJM199006143222403 1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease, Lancet, 344, 1383 2002, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3 Tonkin, 2000, Effects of pravastatin in 3260 patients with unstable angina, Lancet, 356, 1871, 10.1016/S0140-6736(00)03257-8 Sacks, 1996, The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, N Engl J Med, 335, 1001, 10.1056/NEJM199610033351401 LaRosa, 1999, Effect of statins on risk of coronary disease, JAMA, 282, 2340, 10.1001/jama.282.24.2340 Cannon, 2004, Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N Engl J Med, 350, 1495, 10.1056/NEJMoa040583 Mondillo, 2003, Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease, Am J Med, 114, 359, 10.1016/S0002-9343(03)00010-X Blankenhorn, 1991, Effects of colestipol-niacin therapy on human femoral atherosclerosis, Circulation, 83, 438, 10.1161/01.CIR.83.2.438 Duffield, 1983, Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis, Lancet, 2, 639, 10.1016/S0140-6736(83)92527-8 Pedersen, 1998, Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S), Am J Cardiol, 81, 333, 10.1016/S0002-9149(97)00904-1 McDermott, 2003, Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease, Circulation, 107, 757, 10.1161/01.CIR.0000050380.64025.07 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 2004, Standards of medical care in diabetes, Diabetes Care, 27, S15 Burns, 2002, Second best medical therapy, Eur J Vasc Endovasc Surg, 24, 400, 10.1053/ejvs.2002.1737 Henke, 2004, Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications, J Vasc Surg, 39, 357, 10.1016/j.jvs.2003.08.030 Mukherjee, 2002, Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions, Circulation, 106, 1909, 10.1161/01.CIR.0000035649.39669.CE